Mark Smithyes
Vorsitzender bei Life Sciences Ontario
Profil
Mark Smithyes is currently the Chairman of Life Sciences Ontario.
He previously served as Chairman of NetraMark Holdings, Inc. in 2021, and held director positions at Medical Technology (W.B.
), Inc. and New Circles Community Services.
From 2016 to 2017, he was the Head-Pharmaceutical Business Unit at Alcon AG.
He was also the President of NetraMark Corp.
from 2021 to 2022 and the President of Labtician Thea, Inc. from 2017 to 2019.
Mr. Smithyes holds an MBA from Kellogg School of Management and an undergraduate degree from Western University.
Aktive Positionen von Mark Smithyes
Unternehmen | Position | Beginn |
---|---|---|
Life Sciences Ontario | Vorsitzender | - |
Ehemalige bekannte Positionen von Mark Smithyes
Unternehmen | Position | Ende |
---|---|---|
NetraMark Corp.
NetraMark Corp. Information Technology ServicesTechnology Services Part of NetraMark Holdings, Inc., NetraMark Corp. is an AI and pharma-tech company based in Toronto, CA. NetraMark was acquired by NetraMark Holdings, Inc. on October 18, 2021 for $11.92 million. The company focuses on developing AI/ML solutions for the pharmaceutical industry, using a novel topology-based algorithm to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows NetraMark to work with much smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. NetraMark's proprietary next-generation AI solutions for pharmaceutical and biotechnology companies allow them to leverage small to large data sets in order to prevent clinical trial failure, identify biomarkers, implement adaptive trials, accelerate drug discovery, and enable drug repurposing and resurrection. The Canadian company was founded in 2016 by Joseph Geraci and Richard Brooks, with Joseph Geraci serving as CEO since then. | Präsident | 14.07.2022 |
NETRAMARK HOLDINGS INC. | Vorsitzender | 22.11.2021 |
Labtician Thea, Inc. | Präsident | 01.01.2019 |
ALCON INC. | Corporate Officer/Principal | 01.01.2017 |
New Circles Community Services | Direktor/Vorstandsmitglied | - |
Ausbildung von Mark Smithyes
Kellogg School of Management | Masters Business Admin |
Western University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NETRAMARK HOLDINGS INC. | Technology Services |
ALCON INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Labtician Thea, Inc. | |
Life Sciences Ontario | |
Medical Technology (W.B.), Inc. | |
New Circles Community Services | |
NetraMark Corp.
NetraMark Corp. Information Technology ServicesTechnology Services Part of NetraMark Holdings, Inc., NetraMark Corp. is an AI and pharma-tech company based in Toronto, CA. NetraMark was acquired by NetraMark Holdings, Inc. on October 18, 2021 for $11.92 million. The company focuses on developing AI/ML solutions for the pharmaceutical industry, using a novel topology-based algorithm to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows NetraMark to work with much smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. NetraMark's proprietary next-generation AI solutions for pharmaceutical and biotechnology companies allow them to leverage small to large data sets in order to prevent clinical trial failure, identify biomarkers, implement adaptive trials, accelerate drug discovery, and enable drug repurposing and resurrection. The Canadian company was founded in 2016 by Joseph Geraci and Richard Brooks, with Joseph Geraci serving as CEO since then. | Technology Services |